For another perspective on the matter, https://blogs.sciencemag.org/pipeline/archives/2021/02/02/myths-of-vaccine-manufacturing https://blogs.sciencemag.org/pip

For another perspective on the matter, https://blogs.sciencemag.org/pipeline/archives/2021/02/02/myths-of-vaccine-manufacturing https://blogs.sciencemag.org/pipeline/archives/2021/02/02/my... Odds are, the licensing issues aren't at all to blame for the supply and distribution problems.